A Study of LY2157299 in Participants With Hepatocellular Carcinoma

Clinical trial NCT01246986 · COMPLETED

Trial details

NCT number: NCT01246986
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Hepatocellular

Start date: 2011-03-30
Primary completion: 2019-06-06
Enrollment: 204

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.